Senti Biosciences Holdings, Inc. (SNTI)
0.2239
0.00 (0.00%)
USD |
NASDAQ |
Oct 19, 16:00
0.22
0.00 (0.00%)
After-Hours: 20:00
Senti Biosciences Holdings Net Income (Quarterly) : -12.75M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.75M |
| March 31, 2026 | -4.221M |
| December 31, 2025 | -14.47M |
| September 30, 2025 | -18.13M |
| June 30, 2025 | -14.73M |
| March 31, 2025 | -14.11M |
| December 31, 2024 | -0.61M |
| September 30, 2024 | -28.87M |
| June 30, 2024 | -11.20M |
| March 31, 2024 | -12.11M |
| December 31, 2023 | -18.69M |
| Date | Value |
|---|---|
| September 30, 2023 | -36.62M |
| June 30, 2023 | -14.25M |
| March 31, 2023 | -13.85M |
| December 31, 2022 | -14.99M |
| September 30, 2022 | -14.30M |
| June 30, 2022 | -11.55M |
| March 31, 2022 | -11.81M |
| December 31, 2021 | -10.90M |
| September 30, 2021 | -11.41M |
| June 30, 2021 | -12.01M |
| March 31, 2021 | -0.0012M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| NovelStem International Corp. | -0.0858M |
| Brainstorm Cell Therapeutics, Inc. | -3.855M |
| Summit Therapeutics, Inc. | -215.70M |
| Kezar Life Sciences, Inc. | -5.756M |
| Protara Therapeutics, Inc. | -21.67M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.017M |
| Total Expenses (Quarterly) | 12.77M |
| EPS Diluted (Quarterly) | -0.4094 |
| Enterprise Value | 20.77M |
| Gross Profit Margin (Quarterly) | -3.82K% |
| Profit Margin (Quarterly) | -75.00K% |
| Earnings Yield | -788.4% |
| Normalized Earnings Yield | -802.86 |